Drug intelligence / Profile preview

Podiacyn

Development stage: Unknown
Lead developer: Sonoma Pharmaceuticals
Modality: Drug Delivery Systems
Administration: Topical

Overview

Podiacyn is an over-the-counter, hypochlorous acid-based topical solution marketed for everyday foot care and hygiene, formulated to reduce microorganisms such as bacteria and fungi that contribute to foot odor, irritation, and minor infections. It is positioned as an all-natural, non-irritating product that supports the body’s natural healing processes on the skin of the feet and is derived from Sonoma Pharmaceuticals’ stabilized hypochlorous acid technology used in other wound and skin-care solutions.[1][2][3][7]

Brand names: Podiacyn

Beyond the preview

Go deeper on Podiacyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Podiacyn.

Explore the full profile